Modification of infant hypothyroidism and phenylketonuria screening program using electronic tools

Modification of infant hypothyroidism and phenylketonuria screening program using electronic tools

BACKGROUND Congenital hypothyroidism and phenylketonuria (PKU) are the most common cause for preventable mental retardation in infants worldwide. Timely diagnosis and treatment of these disorders can have lasting effects on the mental development of newborns. However, there are several problems at different stages of screening programs that along with imposing heavy costs can reduce the precisi...

Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening.

This study was to investigate the current status of neonatal screening in China, to further clarify the incidences of hyperphenylalaninemia (HPA) and congenital hypothyroidism (CH). From 2000 to 2007, a total of 17,961,826 newborns had been screened for HPA and 1527 cases were detected, giving a HPA prevalence of 1:11,763. At the same time, 18,284,745 newborns had also been tested for CH, with ...

Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism

Audit of neonatal screening programme for phenylketonuria and congenital hypothyroidism.

The performance of the neonatal screening programme was audited against clinical standards in the Bath clinical area from 1 April 1994 to 31 March 1996. The standards and policy were agreed by local service provider representatives of the screening and were audited, using laboratory and child health computer systems and medical records. Two annual reports were produced with recommendations for ...

Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism